A Cross-Sectional Study of Cannabidiol Users.

Area of Science:

• Pharmacology
• Cannabinoid research
• Public health

Background:

• Cannabidiol (CBD) shows therapeutic potential but faces regulatory challenges in the U.S.
• Despite its status, consumer demand for CBD products is high and growing.
• Limited research exists on the specific reasons behind increasing CBD utilization.

Purpose of the Study:

• To investigate the demographics, usage patterns, and motivations of individuals using CBD.
• To characterize the perceived efficacy and adverse effects of CBD products.
• To understand the role of CBD in self-treatment for various medical conditions.

Main Methods:

• An online survey was distributed to a self-selected convenience sample of 2409 participants.
• Data collection occurred from October 25, 2017, to January 25, 2018, with recruitment via social media.
• The anonymous questionnaire focused on 'who, how, and why' individuals use CBD.

Main Results:

• Approximately 62% of CBD users reported using it for a medical condition, primarily pain, anxiety, and depression.
• Nearly 36% found CBD very effective for their condition, while only 4.3% reported low efficacy.
• One-third of users reported non-serious adverse effects; non-regular cannabis users were more likely to use CBD for medical reasons.

Conclusions:

• Consumers are actively using CBD as a targeted therapy for diverse medical issues, including pain, anxiety, depression, and sleep disorders.
• The findings highlight a significant consumer-driven demand for CBD as a treatment.
• Further research into CBD's therapeutic potential is strongly indicated by these consumer usage patterns.